Agenus Inc.
Anti-ILT4 antibodies and antigen-binding fragments
Last updated:
Abstract:
The present invention provides antibodies and antigen-binding fragments thereof that bind to ILT4 (immunoglobulin-like transcript 4) and combinations thereof, e.g., with an anti-PD1 antibody. Also provided are methods of use thereof, for example, for treating or preventing cancer in a subject; and methods of making such antibodies and fragments.
Status:
Grant
Type:
Utility
Filling date:
5 Apr 2018
Issue date:
6 Jul 2021